Monday, May 02, 2022 9:20:12 PM
https://www.defenseworld.net/2022/04/27/io-biotech-inc-s-lock-up-period-set-to-end-on-may-4th-nasdaqiobt.html
Recent IOBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:30:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:13:53 PM
- IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 05/14/2024 11:55:00 AM
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:30:00 PM
- IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103 • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
- IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/05/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 08:56:44 PM
- IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/06/2024 09:11:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:46:56 PM
- IO Biotech Announces 2023 Fourth-Quarter and Year-End Results • GlobeNewswire Inc. • 03/05/2024 09:40:01 PM
- IO Biotech to Present at 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:11:55 PM
- IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial • GlobeNewswire Inc. • 12/21/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 10:37:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:37 PM
- IO Biotech Announces 2023 Third Quarter Results • GlobeNewswire Inc. • 11/13/2023 01:12:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:10:53 PM
- IO Biotech Appoints Helen Collins, MD, to its Board of Directors • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- IO Biotech Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/08/2023 09:30:00 PM
- IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting • GlobeNewswire Inc. • 11/01/2023 12:30:00 PM
- Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Socie • GlobeNewswire Inc. • 10/23/2023 05:00:00 AM
- IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting • GlobeNewswire Inc. • 10/03/2023 08:30:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM